Marie-Cecile van de Lavoir
Chief Tech/Sci/R&D Officer bei OMNIAB, INC.
Profil
Marie-Cecile van de Lavoir is the founder of Crystal Bioscience, Inc. which was founded in 2008, where she holds the title of Chief Operating Officer.
She currently holds the position of Vice President-Operations at OmniAb Operations, Inc. and Senior VP-Technical Operations & Genetics at OmniAb, Inc. Dr. van de Lavoir has a doctorate degree from the University of Guelph and the University of Utrecht.
Aktive Positionen von Marie-Cecile van de Lavoir
| Unternehmen | Position | Beginn |
|---|---|---|
| OMNIAB, INC. | Chief Tech/Sci/R&D Officer | - |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Chief Operating Officer | - |
Crystal Bioscience, Inc.
 Crystal Bioscience, Inc. BiotechnologyHealth Technology Crystal Bioscience, Inc. provides health screening services. The firm offers crystal antibodies, Her2 Model, HuMab chicken, single B-cell screening, and in-vivo molecular evolution. The company was founded by Rob Etches, Marie-Cecile van de Lavoir, and Bill Harriman in 2008 and is headquartered in Emeryville, CA. | Founder | 01.01.2008 |
Ausbildung von Marie-Cecile van de Lavoir
| University of Guelph | Doctorate Degree |
| University of Utrecht | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OMNIAB, INC. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Crystal Bioscience, Inc.
Crystal Bioscience, Inc. BiotechnologyHealth Technology Crystal Bioscience, Inc. provides health screening services. The firm offers crystal antibodies, Her2 Model, HuMab chicken, single B-cell screening, and in-vivo molecular evolution. The company was founded by Rob Etches, Marie-Cecile van de Lavoir, and Bill Harriman in 2008 and is headquartered in Emeryville, CA. | Health Technology |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
